Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects-Reference-Cited by-同舟云学术

Bioequivalence of Saxagliptin/Metformin Extended-Release (XR) Fixed-Dose Combination Tablets and Single-Component Saxagliptin and Metformin XR Tablets in Healthy Adult Subjects

Published:2011-09 Issue:9 Volume:31 Page:619-630
ISSN:1173-2563
Container-title:Clinical Drug Investigation
language:en
Short-container-title:Clinical Drug Investigation

Author:

Boulton David W.,Smith Charles H.,Li L.,Huang Jian,Tang Angela,LaCreta Frank P.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),General Medicine

Reference8 articles.

1. An overview of the rationale for pharmacological strategies in type 2 diabetes: from the evidence to new perspectives

2. Dipeptidyl peptidase-4 inhibitors in the treatment of type 2 diabetes: a comparative review

3. Inhibitor selectivity in the clinical application of dipeptidyl peptidase-4 inhibition

4. Metformin Effects on Dipeptidylpeptidase IV Degradation of Glucagon-like Peptide-1

5. Reduced serum dipeptidyl peptidase-IV after metformin and pioglitazone treatments

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical outcomes in non-small-cell lung cancer patients receiving concurrent metformin and immune checkpoint inhibitors;Lung Cancer Management;2019-10

2. Influence of Human Biorhythms on the Blood Glucose Level and the Efficacy of Hypoglycemic Drugs (Review);Pharmaceutical Chemistry Journal;2017-08

3. Metformin: New Preparations and Nonglycemic Benefits;Current Diabetes Reports;2017-01

4. Pharmacokinetics of the evogliptin/metformin extended-release (5/1,000 mg) fixed-dose combination formulation compared to the corresponding loose combination, and food effect in healthy subjects;Drug Design, Development and Therapy;2016-04

5. Bioequivalence, Food Effect, and Steady‐State Assessment of Dapagliflozin/Metformin Extended‐release Fixed‐dose Combination Tablets Relative to Single‐component Dapagliflozin and Metformin Extended‐release Tablets in Healthy Subjects;Clinical Therapeutics;2015-07